SETDB1 and neoplasm: We found that SETDB1 knockdown significantly reduced AKT activation and CSF-1 protein expression in the xenograft model, while SETDB1 overexpression remarkably promoted AKT activation and CSF-1 protein levels in xenograft tumor tissues (Fig. 5g and h).